Report: Mylan Might See Higher Bid From Teva

By: via Benzinga
Mylan NV (NASDAQ: MYL) shares were unmoved by an unconfirmed report Friday that it might get a sweetened bid from Teva Pharmaceutical ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.